Dechra HY-50 is a sterile sodium hyaluronate chondroprotectant for horses, formulated at 17 mg/mL in a 3 mL syringe (51 mg total). It is indicated for the treatment of carpal or fetlock joint dysfunction due to non-infectious synovitis associated with equine osteoarthritis. For intra-articular and/or intravenous administration by a veterinarian, HY-50 provides targeted equine joint care as indicated on the label. A trusted livestock health product for horse owners seeking veterinarian-directed horse joint support. DIN 02238566; prescription required in Canada.